Evidence map›Paper›PMID 26588686›Full record

ArticlePloS one2015

Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.

Lindsay E Calderon, Shu Liu, Nova Arnold, Bethany Breakall, Joseph Rollins, Margaret Ndinguri

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Nicotine mediated epithelial modulations: AnJournal of oral biology and craniofacial research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lindsay E CalderonDepartment of Biology, Eastern Kentucky University, Richmond, KY, 40475, United States of America.
Shu LiuDepartment of Physiology, Hebei University Health Science Center, Hebei, 071000, China.
Nova ArnoldDepartment of Biology, Eastern Kentucky University, Richmond, KY, 40475, United States of America.
Bethany BreakallDepartment of Biology, Eastern Kentucky University, Richmond, KY, 40475, United States of America.
Joseph RollinsDepartment of Biology, Eastern Kentucky University, Richmond, KY, 40475, United States of America.
Margaret NdinguriDepartment of Chemistry, Eastern Kentucky University, Richmond, KY, 40475, United States of America.
Eastern Kentucky University · USHebei University · CN

Funding

Kentucky Bridge to a Biomedical Doctorate for Appalachian StudentsR25GM102776 · NIGMS · UNIVERSITY OF KENTUCKY · PI SPEAR, BRETT T · 2012 to 2016
$1.8M
NIGMS NIH HHS GM102776NIGMS NIH HHS R25 GM102776
6 · The paper itself

Abstract

objectivesCalcium independent group VIA phospholipase A2 (iPLA2β) and Matrix Metalloproteinase-9 (MMP-9) are upregulated in many disease states; their involvement with cancer cell migration has been a recent subject for study. Further, the molecular mechanisms mediating nicotine-induced breast cancer cell progression have not been fully investigated. This study aims to investigate whether iPLA2β mediates nicotine-induced breast cancer cell proliferation and migration through both in-vitro and in-vivo techniques. Subsequently, the ability of Bromoenol Lactone (BEL) to attenuate the severity of nicotine-induced breast cancer was examined. METHOD AND

resultsWe found that BEL significantly attenuated both basal and nicotine-induced 4T1 breast cancer cell proliferation, via an MTT proliferation assay. Breast cancer cell migration was examined by both a scratch and transwell assay, in which, BEL was found to significantly decrease both basal and nicotine-induced migration. Additionally, nicotine-induced MMP-9 expression was found to be mediated in an iPLA2β dependent manner. These results suggest that iPLA2β plays a critical role in mediating both basal and nicotine-induced breast cancer cell proliferation and migration in-vitro. In an in-vivo mouse breast cancer model, BEL treatment was found to significantly reduce both basal (p<0.05) and nicotine-induced tumor growth (p<0.01). Immunohistochemical analysis showed BEL decreased nicotine-induced MMP-9, HIF-1alpha, and CD31 tumor tissue expression. Subsequently, BEL was observed to reduce nicotine-induced lung metastasis.

conclusionThe present study indicates that nicotine-induced migration is mediated by MMP-9 production in an iPLA2β dependent manner. Our data suggests that BEL is a possible chemotherapeutic agent as it was found to reduce both nicotine-induced breast cancer tumor growth and lung metastasis.

Indexed as

AnimalsAnticarcinogenic AgentsCarcinogensCell Line, TumorCell MovementCell ProliferationEpithelial CellsFemaleGene Expression Regulation, NeoplasticGroup VI Phospholipases A2Hypoxia-Inducible Factor 1, alpha SubunitLung NeoplasmsMammary Glands, AnimalMammary Neoplasms, ExperimentalMatrix Metalloproteinase 9Mice6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-oneAnticarcinogenic AgentsCarcinogensGroup VI Phospholipases A2Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMatrix Metalloproteinase 9NaphthalenesNicotinePla2g6 protein, mousePlatelet Endothelial Cell Adhesion Molecule-1Pyrones

Identifiers

PMID26588686
PMCPMC4654479
OpenAlexW2178336708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.